Literature DB >> 18946170

Investigation of blood lipid levels and statin interventions in outpatients with coronary heart disease in China: the China Cholesterol Education Program (CCEP).

Dayi Hu1, Jue Li, Xiankai Li.   

Abstract

BACKGROUND: The aim of the China Cholesterol Education Program is to investigate the blood lipid levels, the statin intervention and the rates of achieving the goal of low-density lipoprotein-cholesterol (LDL-C) level in Chinese outpatients with coronary heart disease (CHD). METHODS AND
RESULTS: The multicenter study recruited 4,778 outpatients with CHD. The mean level of LDL-C for the total outpatients was 2.93+/-1.00 mmol/L; 82.2% of the participants received statin therapy. The LDL-C levels were 3.06+/-1.08 mmol/L and 2.89+/-0.97 mmol/L in outpatients with high risk and very high risk, respectively (p<0.001). No significant difference was found about the rates of statin intervention in outpatients at high risk and very high risk (81.4% vs 82.5%, p>0.05). Though they had higher rates of statin intervention, only 36.2% of the high-risk outpatients achieved the target LDL-C level (<2.6 mmol/L); 10.9% of the very high risk outpatients achieved the optimal LDL-C level (<1.82 mmol/L) suggested by NCEP ATP III. The rate of achieving the target level was only 42.2%, even though LDL-C <2.6mmol/L was the goal for patients at very high risk.
CONCLUSIONS: Although the outpatients received a higher rate of statin therapy, the rates of achieving the target cholesterol level were lower. There is a significant gap between the guidelines and clinical practice in China.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946170     DOI: 10.1253/circj.cj-08-0417

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

Review 1.  Barriers to translating EU and US CVD guidelines into practice in China.

Authors:  Dong Zhao; Dayi Hu
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

2.  The specialty of pulmonary vascular medicine in China: historical development and future directions.

Authors:  Hua Luo; Jingwen Li
Journal:  Cardiovasc Diagn Ther       Date:  2012-09

3.  Factors associated with lipid goal attainment among acute coronary syndrome patients.

Authors:  Siti-Zainora Mohd-Zulkefli; Marhanis-Salihah Omar; Adyani Md-Redzuan
Journal:  Patient Prefer Adherence       Date:  2016-08-24       Impact factor: 2.711

4.  Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.

Authors:  Xiqian Huo; Erica S Spatz; Qinglan Ding; Paul Horak; Xin Zheng; Claire Masters; Haibo Zhang; Melinda L Irwin; Xiaofang Yan; Wenchi Guan; Jing Li; Xi Li; John A Spertus; Frederick A Masoudi; Harlan M Krumholz; Lixin Jiang
Journal:  BMJ Open       Date:  2017-12-21       Impact factor: 2.692

Review 5.  Cardiovascular diseases in China: Current status and future perspectives.

Authors:  Hua Li; Junbo Ge
Journal:  Int J Cardiol Heart Vasc       Date:  2014-12-30

6.  Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese Cholesterol Education Program.

Authors:  Dachun Xu; Wei Chen; Xiankai Li; Yi Zhang; Xin Li; Hou Lei; Yidong Wei; Weiming Li; Dayi Hu; Nicole M Wedick; Jinsong Wang; Yawei Xu; Jue Li; Yunsheng Ma
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.